The startup develops medical imaging devices that provide real-time tumor tracking and low-cost radiotherapy, enabling image-guided cancer therapy and non-invasive cardiac imaging. By offering affordable and diverse imaging solutions, the company enhances access to essential medical technologies for healthcare providers.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conventional medical imaging and radiotherapy equipment for cancer therapy can be expensive and may not provide real-time tumor tracking, potentially limiting access to advanced treatment options and precision in targeting tumors. Existing cardiac imaging techniques may also be invasive or lack the necessary resolution for detailed diagnostics.
Solution
Imatrex developed medical imaging devices designed to provide real-time tumor tracking during radiotherapy, enabling image-guided cancer therapy. The company's technology aimed to offer a lower-cost alternative to traditional systems, potentially increasing access to advanced medical imaging for healthcare providers. Their solutions also included non-invasive cardiac imaging capabilities, providing diverse imaging solutions for different medical needs. While the company's operations are currently on pause, they continue to service existing Imatron EBCT Scanners in the U.S.
Target Audience
The primary target audience included healthcare providers, such as hospitals and clinics, seeking affordable and diverse medical imaging solutions for cancer therapy and cardiac diagnostics.
Features
- Real-time tumor tracking during radiotherapy procedures
- Image-guided cancer therapy capabilities
- Low-cost radiotherapy solutions
- Non-invasive cardiac imaging technology
- Advanced equipment for medical imaging